Please login to the form below

Not currently logged in
Email:
Password:

Cello Health appoints digital leaders in the US

Rick Lang and Craig Lipski join in senior roles

Cello Health Communications Rick Lang Craig Lipski 

Cello Health Communications has appointed Rick Lang (pictured left) and Craig Lipski to digital leadership roles at its US organisation.

Lang has been named senior vice president, digital in a role that hands his responsibility for the strategic vision of the firm's digital capability.

He joins Cello from Huntsworth Health agency ApotheCom, where he served as senior vice president, digital for two and a half years, and prior spent three and a half years as vice president, communications technology at Huntsworth's The APO Group.

Lang said: “The word digital has so quickly come and gone as a focus. The tools and experiences that were once labelled as digital, simply because of novelty, are now the fabric of the world we live in. 

“I am so excited to be part an organisation that is appropriately concentrated on the one capability that truly differentiates, with evidence at our core and a sole focus on strategic content development.”

Meanwhile Lipski also arrives at Cello from ApotheCom, where he was senior director, application development. 

In his new role Lipski will be responsible for leading the interactive arm of the Cello Health Communications digital capability.

John Howley, managing director at Cello Health Communications - MedErgy, said: “Adding the expertise that Rick and Craig bring to the organization will allow us to leverage our strength in developing highly scientific content into new offerings to more effectively engage our clients' stakeholders to drive behavioural change.”

15th August 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics